Primary bile acids are called as cholic acid and chenodeoxycholic acid those are synthesized from the cholesterol in liver. Oral cholic acid is used for the treatment given in case of bile acid synthesis disorders. These disorders due to the single enzyme defects. Due to the less number of patient with the deficiency in the bile acid synthesis, this condition is considered a rare disease condition. Hence the Cholic acid was identified as ‘orphan medicine’. Cholic Acid, decrease the production of the abnormal bile acid and helps to maintain the normal activity of the bile juice in the digestive system. So the person gets relief from the symptoms of the bile disorders. The side effects associated with the Cholic acid treatment are a rise in transaminases level, itching on the skin, diarrhea, and possibility of gallstone generation. Cholic acid treatment should be avoided in the people with hypersensitivity or the people taking the phenobarbital medicine
Rising patient pool suffering from the gall balder cancer may show the propelling growth for the cholic acid market. People suffering from the gall bladder stone related problem may treated with the cholic acid, increasing demand of the gall bladder stone disorder treatment may show the good growth for the cholic acid market. Day by day the geriatric population is increasing those are suffering from the bile juice and indigestion problems, such population may boost the growth of the cholic acid market. People suffering from the obesity may show more demand for the cholic acid for the hormonal therapy on the obesity, since the cholic acid help to maintain the liver hormonal level. Awareness in the people about the gall bladder related disorders may show the slower growth to the cholic acid market. Alternative treatment on the gall bladder disorders may leads to the stagnancy in the cholic acid market
The global cholic acid market is classified on the basis of application, end user and region.
Based on application, cholic acid market is segmented into the following:
Based on end user, cholic acid market is segmented into the following:
Rising population for the gall bladder disorders is the key factor behind the growth of cholic acid market, based on the application, medicine segment will show the maximum revenue for the cholic acid market in future, due to high number of the people suffering from the gall bladder related disorders. Followed by the medicinal purpose, cholic acid used in as organic acid in the various synthetic reaction in the pharma-biotech industries, in coming days organic acid segment may show the lucrative growth for cholic acid market. Emuslsifier segement may show the slow but growing rate for the cholic acid market, due to the use of cholic acid in the emulsification process in the cosmetic and pharmaceutical products.By end user hospitals will show the more revenue for the cholic acid market, as the number of the people visiting to the hospitals are more for the bile disorders. After the hospitals, ambulatory surgical centers may show the good revenue for the cholic acid market, due to the more number of people visiting to the obesity treatment to the ambulatory surgical centers.
Among the regional presence, North America is the more revenue sharing region for cholic acid market which is then followed by Europe. North America accounts to be the leading revenue generating segment due to the growing population of liver cancer and liver related disorders in U.S. and Canada. North America and Europe cumulatively account for a substantial revenue share in cholic acid market. However, due to high prevalence of gall balder cancer in India and China is the main factor behind the robust the growth of cholic acid market in South Asia and East Asia region. However, Middle East and Africa are expected to account for being least lucrative market for cholic acid due to lack of awareness about the gall bladder related disorders in people.
Some of the key players across the value chain of cholic acid market are Merck KGaA, Alchem International Pvt. Ltd., Dr. Falk Pharma GmbH., Suzhou Tianlu Bio-pharmaceutical Co., Ltd., Zhongshan Belling Biotechnology Co.,Ltd., Shanghai Tauto Biotech Co., Ltd., MANUS AKTTEVA, Dipharma Francis Srl., ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD and others.
The report on Cholic acid market covers exhaustive analysis on:
Regional analysis for Cholic acid market includes
Report on Cholic acid market highlights: